|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
R&D 100 Award-Winning Bacterial Culture System Is Available From EMD Biosciences, Inc.; EMD Biosciences Attends 2004 R&D 100 Award Ceremony
10/19/2005 5:12:23 PM
EMD Biosciences, Inc. (www.emdbiosciences.com; EMD Biosciences), a major supplier of premium tools for proteomics and disease pathway analysis known through its global brands Calbiochem(R), Novabiochem(R), and Novagen(R), today announced that F. William Studier, a biophysicist at Brookhaven National Laboratory (www.bnl.gov/world), received a 2004 R&D 100 award for developing an improved system for high-density growth of bacterial cells to produce recombinant proteins. EMD Biosciences is part of the Life Science and Analytics (LSA) division of Merck KGaA (www.merck.de; Darmstadt, Germany) and operates as EMD Biosciences, Inc. in North America and Merck Biosciences outside North America.
|
|
|
|
|
|
|
|
|
|
|